
CDC Opens Review & BLM Scandal | 4.7.22
Morning Wire
00:00
Regulatory Shifts and BLM Controversies
This chapter explores the evolving regulatory landscape for Chinese companies in the U.S., heightened by the COVID-19 crisis in Shanghai, while also delving into the financial scrutiny faced by the Black Lives Matter organization over its real estate purchases and leadership transparency. The analysis raises critical questions about accountability, donor rights, and the implications of these issues on broader U.S.-China relations and social justice movements.
Play episode from 06:36
Transcript


